Second cities in source markets: the demand your competitors ignore

Second city demand is the international patient volume sitting outside capital cities, where almost nobody is competing for attention and the referral chain runs through local specialists nobody visits. It is cheaper to reach and harder to serve, because families face a domestic journey before the international one. Finding it starts in your own arrival data, not in a market report.

Look at where your international arrivals actually live, not where they flew from. In most hospitals nobody has done this, because the enquiry record captures a country and a phone number and stops there. When a desk does the exercise, the same pattern usually appears: a large share of arrivals come from one or two cities, and a long, scattered tail comes from places nobody has ever planned for.

That tail is second city demand, and it is the part of medical value travel that the industry consistently under-serves. Every hospital with an international ambition is competing for the same attention in the same capitals, against each other and against destinations in other countries. A few hours inland, the same conditions exist, the same families are looking for the same answers, and almost nobody is talking to them.

It is not free money. These cities are harder to serve, the referral chain is different, and the journey is longer at the patient’s end. But the competition is thin enough that a modest, well designed effort produces results that would need a much larger budget in the capital.

What counts as a second city in this context

Not simply the second largest city by population. What matters operationally is a place with three features: a meaningful patient population, a local medical community that refers cases onward, and an inconvenient relationship with the capital. That last feature is the one that creates the opportunity, because inconvenience is what stops families and doctors from engaging with the usual channels.

In practice these are regional centres several hours from the main airport. They have hospitals and specialists but not the full range of tertiary services. Families there already travel for care, usually first to their own capital, and sometimes onward. They are used to the idea of going somewhere else for treatment, which is the single most useful precondition you can find in any market.

Some of them sit closer to a border than to their own capital, and the practical route out of the country may not be the obvious one. Others have an industry or a trading relationship that produces regular travel to India already. Both are worth knowing before you decide where to spend.

Why second city demand stays unserved

Three reasons, and none of them is that the demand is not there.

The first is measurement. Most international desks record country, not city, so the demand is invisible in their own reporting. You cannot decide to serve a market you have never counted, and the absence of a field becomes the absence of a strategy.

The second is that the intermediaries who dominate these markets are based in capitals, and they work with what is in front of them. A facilitator in a capital city has enough demand locally and little reason to develop a network several hundred kilometres away. So if you rely entirely on that layer, you inherit its geography.

The third is that serving these cities requires work that does not scale neatly: content in a regional language variant, relationships with individual doctors, patience with a longer journey. Marketing teams under pressure to show volume gravitate to the capital because the numbers arrive faster. That is a rational choice and it is why the space stays open. The general discipline of counting before deciding is the subject of reading international demand from data rather than anecdotes, and second cities are where the absence of counting costs the most.

Finding these cities inside your own data

Start with what you already have. Your arrived patients came from somewhere specific, and that information exists in admission records, passports and conversations even if nobody has aggregated it. Add a city field to your international enquiry record, backfill what you can from the last two years of arrivals, and look at the distribution.

Then look at three other sources. Search data by region, in the local language, shows where queries for your procedures are coming from inside a country and how thin the competition is outside the capital. Your own site analytics, read by region rather than country, shows which places already find you. And your discharged patients will tell you, if asked, which local doctor referred them and which city they travel to for specialist care.

Two cautions. Small numbers are noisy, so look at two years rather than one quarter before drawing a line. And treat a cluster of enquiries from one city as a hypothesis, not a finding, until you have asked a few families how they heard of you. A single active former patient can produce a cluster that looks like a market. How to count all of this honestly, including the gap between enquiries and arrivals, is set out in measuring international demand honestly.

One more input is easy to overlook: how people actually leave the country. Which airport a regional city uses, whether the route runs through its own capital or through a neighbouring hub, and how often flights operate all shape what is realistic. A city with an awkward connection can still be a good market, but the length of stay, the timing of arrivals and the cost of a repeat visit will all differ from the capital, and your pathway should reflect that rather than assume it.

The referring doctor nobody has ever visited

In a capital city, a specialist has been approached by hospitals from several countries. In a regional city, often nobody has come at all. That asymmetry is the most valuable thing about these markets, and it is available to any hospital willing to do unglamorous relationship work.

What these doctors want is not hospitality. It is a colleague who answers. A second opinion returned within a stated time. A discharge summary that arrives complete, in a usable form, naming them as the referring physician. A route to ask a question about a patient they sent six months ago and get a real answer. Teleconsultation that includes them rather than going around them. Case discussions that treat them as the continuing clinician rather than a source of leads.

Build it as a programme with a name, an owner and a record, not as a series of visits by whoever is travelling. Keep a list of who has referred, what happened to each case and when they were last contacted. The structure of that, including how to handle the fact that a referring doctor abroad has no obligation to you at all, is worth treating as its own product, which I have written about in building a referral network outside India.

Language changes inside a country, not just between countries

A capital city usually operates comfortably in the country’s main working language, often with English alongside it. Move inland and that changes. A regional language or a dialect may be what families actually speak at home, older relatives may not use the capital’s language easily, and the person who writes to you in English may be a younger relative translating for everyone else.

Handle this as service design rather than as an obstacle. Find out which language the family will actually be spoken to in on the ward, before they arrive, and record it in the case file. Make sure your interpreter cover includes the variants that matter for the cities you are targeting, not only the standard form. Where you publish content, a page in the language people search in will outperform a page in the official language of a country, and it will be almost uncontested.

What patients type differs by region as well as by country, which is why keyword work done once for a whole market tends to miss these cities entirely. The detail on that sits in search behaviour by source market.

The domestic leg nobody plans for

For a family in a regional city, your hospital is not one flight away. It is a road journey, then a night somewhere, then a flight, possibly with a connection. Add paperwork that may only be processed in the capital, and money that may have to be arranged in person, and the trip starts several days before the one your desk is planning.

This changes the case in ways worth designing for:

• Families make fewer trips, so they try to settle everything in one visit, which raises the value of a pre travel consultation and of clarity about what can be done at home.
• They arrive tired, often late at night, after two or three days of travel, so the first twelve hours need to be gentler than your standard process assumes.
• Repeat travel for review is a real burden, so remote follow up is not a convenience, it is the difference between a completed course of care and a patient lost to follow up.
• Length of stay tends to run longer, because going home and coming back is not practical.

None of that requires investment. It requires that somebody maps the journey from the patient’s front door rather than from your airport pickup.

Camps, visiting clinics and information sessions, done honestly

The obvious way to reach a regional city is to go there, and it is often the right one. It is also the activity most likely to create a compliance problem, so set the rules before the first trip.

My own line is straightforward. An information session is information, not diagnosis. Nobody is told they need surgery in a hotel conference room. No outcome is promised, no comparison with local care is made, and no clinical opinion is given without reports and a proper consultation. Data collected is collected with consent, stored properly, and used only for what the person agreed to. Local rules on medical practice, advertising and data apply and must be checked with someone qualified in that country before anything is arranged, not afterwards.

Within those limits, presence works. A consultant who travels regularly, on a predictable schedule, and holds sessions with local doctors rather than only with patients, builds something no campaign reproduces. So does a local coordinator who is reachable in the same time zone and speaks the language. Consistency is what counts. A single visit with no follow up is worse than not going, because it raises expectations and then disappears.

Whatever you do there, keep the patient record and the consent trail with you rather than with a local partner. A relationship built through someone else is a relationship you will lose when that person changes their arrangements, and a consent obtained by somebody else is not a consent you can rely on.

Designing the first test, and how to judge it

Pick one country you already receive patients from and one city inside it that shows up in your own data. Pick one procedure family where you have a genuine clinical strength. That narrowness is the whole point, because a broad test across several markets will produce numbers too small to read anywhere.

Then build four things: a page in the language people there actually search in, a named coordinator who covers that time zone, a second opinion route with a stated turnaround, and a list of local doctors with a plan for contacting them that does not depend on a single trip. Run it for two quarters. Judge it on arrivals, on how many enquiries went silent, and on cost per arrival, not on enquiry volume or conversion rate, which are unreadable at small numbers.

Write down in advance what result would make you widen the test and what result would make you stop. Then actually honour it. The same logic applies inside India, where families in smaller cities travel to metros for care and are reached in a similar way, a pattern I have described in domestic medical travel from smaller cities. The international version is the same idea with a border, a language and a longer journey added, and the reason it works is unchanged: go where the attention is cheap and the service is missing.

Questions people ask